Achieved annual guidance with $1 billion in specialty-driven EBITDA, supported by a solid fourth quarter across all four business segments. Executed a strategic pivot to focus on two high-growth engines: specialty crop nutrition and specialty food solutions, while de-prioritizing less synergetic activities. Acquired Bartek Ingredients to deepen the specialty food portfolio, specifically targeting food-grade malic and fumaric acids for global distribution. Secured long-term operational certainty thro ...

ICL Group (NYSE:ICL) Q4 2025 Earnings call February 18, 2026 08:30 AM ET Company ParticipantsAnantha Desikan - COOAviram Lahav - CFOElad Aharonson - CEOJoel Jackson - Managing Director of Equity ResearchPeggy Reilly Tharp - VP of Global Investor RelationsRaviv Zoller - ChairmanConference Call ParticipantsBenjamin Theurer - Equity Research AnalystDaanish Rizwan - SVP and Equity Research AnalystOperatorGood morning, ladies and gentlemen, and welcome to the ICL fourth quarter 2025 earnings international confer ...

ICL Group (NYSE:ICL) Q4 2025 Earnings call February 18, 2026 08:30 AM ET Company ParticipantsAnantha Desikan - EVP, Chief Innovation and Technology OfficerAviram Lahav - CFODan Rizzo - SVPElad Aharonson - CEOJoel Jackson - Managing Director of Equity ResearchPeggy Reilly Tharp - VP of Global Investor RelationsRaviv Zoller - ChairmanConference Call ParticipantsBenjamin Theurer - Equity Research AnalystOperatorGood morning, ladies and gentlemen, and welcome to the ICL fourth quarter 2025 earnings internationa ...

ICL Group (NYSE:ICL) Q4 2025 Earnings call February 18, 2026 08:30 AM ET Speaker5Good morning, ladies and gentlemen, and welcome to the ICL fourth quarter 2025 earnings international conference call. At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call require immediate assistance, please press star zero for the operator. I would now like to turn the conference call over to Peggy Reilly Tharp, Vice Presi ...

2025 Fourth Quarter Financial Results AI & Innovation as Key Enablers Note: Specialty crop nutrition is part of the Growing Solutions division; Specialty food solutions is part of food specialties under the Phosphate Solutions division. 3 Optimization Elad Aharonson | President and CEO February 18, 2026 Important legal notes Disclaimer and safe harbor for forward-looking statements This presentation contains statements that constitute "forward-looking statements," many of which can be identified by the use ...

Core Viewpoint - ICL, a leading global specialty minerals company, reported its financial results for Q4 and the full year ended December 31, 2025, highlighting a mixed performance with increased sales but decreased operating income [1] Financial Performance - Consolidated sales for Q4 reached $1,701 million, representing a 6% increase compared to $1,601 million in Q4 2024 [1] - Operating income for Q4 was reported at ($16) million, a significant decline from $147 million in the same quarter of the previous year [1] - Adjusted operating income for Q4 was $223 million, which is a 17% increase from $190 million in Q4 2024 [1]

Core Viewpoint - The company has released an immediate report regarding the concession, which serves as a formalization and final realization of the situation [1]. Group 1 - The presentation was led by Peggy Tharp, Vice President of Global Investor Relations, who welcomed participants and acknowledged the presence of international attendees [1]. - Elad is expected to provide prepared remarks following the initial update on the concession [2].

Summary of Conference Call Company and Industry - The conference call pertains to a company involved in concessions with the State of Israel, specifically focusing on asset valuation and transition processes related to the concession agreement. The company is likely involved in the bromine and periclase industries, which are part of the chemical sector. Core Points and Arguments - **Final Agreement with the State of Israel**: The company signed a final and binding agreement with the State of Israel regarding asset valuation of **$2.54 billion** and additional investments in a permanent salt harvesting project amounting to **hundreds of millions** [4][5] - **Payment Schedule**: The payment schedule includes **95%** of the total consideration to be paid on **April 1, 2030**, with the remaining **5%** due on **September 1, 2030** [7][8] - **No Setoff Rights**: The agreement includes a critical clause that the state will have no right of setoff against the total consideration, which is significant for the company [8][10] - **Operational Continuity**: The agreement ensures a continued supply of required raw materials for downstream operations until **2035**, which is five years beyond the end of the current concession [9][10] - **Profitability Expectations**: The company does not expect a material change in the profitability of its downstream or concession operations until at least **2035** [10] - **Future Concession Process**: The company will cooperate with the tender process for the new concession, which is expected to conclude legislation within a year, followed by a pre-qualification phase for bidders [16][34] - **National Security Considerations**: Future limitations may be placed on foreign competitors regarding ownership of concessions based on national security interests [19][21] Other Important Content - **Management Strategy**: The company emphasizes proactive management of the concession process to avoid prolonged arbitration or legal disputes, which could drain resources [6][11] - **Preparedness for Alternatives**: The company is preparing for scenarios where it may not be the new concession holder, including developing alternative sourcing options for bromine and other materials [31] - **Timeline for New Concession**: The government plans to issue a Request for Proposal (RFP) in **2027** and aims to select the next concession holder by the end of **2027**, with allocation expected by early **2028** [35] This summary captures the essential elements discussed during the conference call, focusing on the agreement with the State of Israel, operational strategies, and future concession processes.

ICL Group (NYSE: ICL) Conference Call Summary Company Overview - **Company**: ICL Group - **Date of Call**: January 28, 2026 - **Focus**: Agreement with the State of Israel regarding asset valuation and transition process Key Points of the Agreement 1. **Asset Valuation**: The company has agreed on an asset valuation of **$2.54 billion**, with additional investments in the permanent Salt Harvesting Project amounting to **hundreds of millions** [3][4] 2. **Payment Schedule**: - **95%** of the total consideration will be paid on **April 1, 2030** - The remaining **5%** will be paid on **September 1, 2030** [6][7] 3. **No Setoff Rights**: The state will have no right of setoff against the total consideration, which is a critical clause for the company [7][9] 4. **Operational Continuity**: The agreement secures the continued supply of required raw materials for downstream operations until **2035**, ensuring no disruption in bromine compounds and periclase production [7][8] 5. **Profitability Expectations**: The company does not expect a material change in profitability for downstream or concession operations until at least **2035** [8][9] 6. **Future Concession**: The company remains confident in being the leading candidate for the new concession, even without the right of first offer [6][10] Strategic Implications - **Long-term Certainty**: The agreement provides long-term certainty for the company, allowing for effective planning and evaluation of new concession options against other strategic alternatives [4][10] - **Proactive Management**: The company aims to manage the transition process proactively to avoid prolonged arbitration or legal disputes [5][10] Timeline for Future Bidding Process - The government plans to conclude new legislation within **one year**, followed by a pre-qualification phase for bidders [15][29] - The Request for Proposal (RFP) is expected to be released in **2027**, with the goal of selecting the next concession holder by the end of **2027** and allocating the concession by early **2028** [30] Additional Considerations - **National Security Arrangements**: Future limitations may be placed on foreign competitors regarding ownership of concessions, reflecting national security interests [18][20] - **Downstream Supply Alternatives**: The company is preparing for scenarios where it may not be the new concession holder, including developing alternative sourcing options beyond bromine [26][27] Conclusion - The call emphasized the importance of the agreement with the State of Israel, providing clarity and stability for ICL Group as it navigates the transition and prepares for future opportunities in the concession landscape [10][33]

Market Performance - The Tel Aviv Stock Exchange experienced a decline, with the Tel Aviv 35 Index falling by 0.08% to 3,968.81 points, the Tel Aviv 125 Index decreasing by 0.85% to 3,987.85 points, and the BlueTech Global Index dropping by 0.10% to 698.43 points [1] - The All Bond corporate bond index decreased by 0.21% to 422.79 points, with total turnover amounting to NIS 3.84 billion in equities and NIS 5.91 billion in bonds [1] Foreign Exchange Rates - The representative shekel-dollar rate increased by 0.701% from Friday, reaching NIS 3.16/$, while the representative shekel-euro rate rose by 0.903% to NIS 3.676/€ [2] Top Gainers - Enlight Renewable Energy saw the largest gain on the Tel Aviv 35 Index, rising by 8.23%. Next Vision increased by 7.69%, and Elbit Systems Ltd. rose by 0.90%. Ormat Technologies Inc. and Bezeq Israel Telecommunications Company Ltd. also experienced gains of 1.13% and 2.17%, respectively [3] Top Losers - Nice recorded the largest decline on the Tel Aviv 35 Index, falling by 5.19%. ICL decreased by 1.95%, and Teva Pharmaceutical Industries Ltd. fell by 1.68%. Mizrahi Tefahot Bank and OPC Energy also saw declines of 1.81% and 1.16%, respectively [4]